FTC - Federal Trade Commission

01/21/2026 | Press release | Distributed by Public on 01/21/2026 10:36

Golden Sunrise Nutraceutical, Inc. - (Case Status: Pending, Last Updated: January 21, 2026)

Last Updated
January 21, 2026
Case Status
Pending
Federal Trade Commission, Plaintiff, v. Golden Sunrise Nutraceutical, Inc., a corporation; Golden Sunrise Pharmaceutical, Inc., a corporation; Huu Tieu, individually and as an officer of Golden Sunrise Nutraceutical, Inc. and Golden Sunrise Pharmaceutical, Inc.; and Stephen Meis, individually and as an officer of Golden Sunrise Nutraceutical, Inc.; Defendants.
FTC Matter/File Number
202 3146
X200051
Civil Action Number
1:20-at-00540
Enforcement Type
Federal Injunctions
Federal Court
Eastern District of California

Case Summary

In July 2020, the Federal Trade Commission filed a complaint in federal court against the California-based marketers and promoters of bogus treatments for serious medical conditions. The defendants are two corporations headquartered in Porterville, California, and two of their executives: Huu Tieu, president and CEO of both companies; and Stephen Meis, Medical Director and board member of Golden Sunrise Nutraceutical. The complaint alleged that defendants have promoted and sold a variety of products through "plans of care" ranging in price from $23,000 to $200,000, which falsely claim to treat or cure COVID-19, cancer, Parkinson's disease, etc. On June 14, 2021, the FTC announced a proposed order barring the defendants from making bogus health claims. In January 2024, the FTC announced the process defrauded consumers can use to seek refunds.

Case Timeline

January 21, 2026
File
Order (214.58 KB)
FTC - Federal Trade Commission published this content on January 21, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 21, 2026 at 16:36 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]